-
1
-
-
14844331708
-
Measles as a potential oncolytic virus
-
Fielding AK. Measles as a potential oncolytic virus. Rev Med Virol 2005;15:135-42.
-
(2005)
Rev Med Virol
, vol.15
, pp. 135-142
-
-
Fielding, A.K.1
-
2
-
-
5644237829
-
Oncolytic measles viruses for cancer therapy
-
Nakamura T, Russell SJ. Oncolytic measles viruses for cancer therapy. Expert Opin Biol Ther 2004;4:1685-92.
-
(2004)
Expert Opin Biol Ther
, vol.4
, pp. 1685-1692
-
-
Nakamura, T.1
Russell, S.J.2
-
3
-
-
0036905014
-
RNA viruses as virotherapy agents
-
Russell SJ. RNA viruses as virotherapy agents. Cancer Gene Ther 2002;9:961-6.
-
(2002)
Cancer Gene Ther
, vol.9
, pp. 961-966
-
-
Russell, S.J.1
-
4
-
-
0034653696
-
Fusogenic membrane glycoproteins as a novel class of genes for the local and immune-mediated control of tumor growth
-
Bateman A, Bullough F, Murphy S, et al. Fusogenic membrane glycoproteins as a novel class of genes for the local and immune-mediated control of tumor growth. Cancer Res 2000;60:1492-7.
-
(2000)
Cancer Res
, vol.60
, pp. 1492-1497
-
-
Bateman, A.1
Bullough, F.2
Murphy, S.3
-
5
-
-
0033959447
-
Cancer gene therapy: Hard lessons and new courses
-
Vile RG, Russell SJ, Lemoine NR. Cancer gene therapy: hard lessons and new courses. Gene Ther 2000;7:2-8.
-
(2000)
Gene Ther
, vol.7
, pp. 2-8
-
-
Vile, R.G.1
Russell, S.J.2
Lemoine, N.R.3
-
6
-
-
0035121424
-
Single-chain antibody displayed on a recombinant measles virus confers entry through the tumor-associated carcinoembryonic antigen
-
Hammond AL, Plemper RK, Zhang J, Schneider U, Russell SJ, Cattaneo R. Single-chain antibody displayed on a recombinant measles virus confers entry through the tumor-associated carcinoembryonic antigen. J Virol 2001;75:2087-96.
-
(2001)
J Virol
, vol.75
, pp. 2087-2096
-
-
Hammond, A.L.1
Plemper, R.K.2
Zhang, J.3
Schneider, U.4
Russell, S.J.5
Cattaneo, R.6
-
7
-
-
0037769825
-
Oncolytic measles viruses displaying a single-chain antibody against CD38, a myeloma cell marker
-
Peng KW, Donovan KA, Schneider U, Cattaneo R, Lust JA, Russell SJ. Oncolytic measles viruses displaying a single-chain antibody against CD38, a myeloma cell marker. Blood 2003;101:2557-62.
-
(2003)
Blood
, vol.101
, pp. 2557-2562
-
-
Peng, K.W.1
Donovan, K.A.2
Schneider, U.3
Cattaneo, R.4
Lust, J.A.5
Russell, S.J.6
-
9
-
-
0002606253
-
The urokinase plasminogen activator system in cancer: Implications for tumor angiogenesis and metastasis
-
Mazar AP, Henkin J, Goldfarb RH. The urokinase plasminogen activator system in cancer: implications for tumor angiogenesis and metastasis. Angiogenesis 1999;3:15-32.
-
(1999)
Angiogenesis
, vol.3
, pp. 15-32
-
-
Mazar, A.P.1
Henkin, J.2
Goldfarb, R.H.3
-
10
-
-
0142188116
-
Urokinase plasminogen activator system: A multifunctional role in tumor progression and metastasis
-
Choong PF, Nadesapillai AP. Urokinase plasminogen activator system: a multifunctional role in tumor progression and metastasis. Clin Orthop Relat Res 2003;415 suppl:S46-58.
-
(2003)
Clin Orthop Relat Res
, vol.415
, Issue.SUPPL.
-
-
Choong, P.F.1
Nadesapillai, A.P.2
-
11
-
-
0347917028
-
The urokinase plasminogen activator system: Role in malignancy
-
Duffy MJ. The urokinase plasminogen activator system: role in malignancy. Curr Pharm Des 2004;10:39-49.
-
(2004)
Curr Pharm Des
, vol.10
, pp. 39-49
-
-
Duffy, M.J.1
-
12
-
-
0032520105
-
Urokinase-type plasminogen activator, its inhibitor, and its receptor in patients with upper urinary tract carcinoma
-
Nakanishi K, Kawai T, Torikata C, Aurues T, Ikeda T. Urokinase-type plasminogen activator, its inhibitor, and its receptor in patients with upper urinary tract carcinoma. Cancer 1998;82:724-32.
-
(1998)
Cancer
, vol.82
, pp. 724-732
-
-
Nakanishi, K.1
Kawai, T.2
Torikata, C.3
Aurues, T.4
Ikeda, T.5
-
13
-
-
0032953135
-
Prognostic value of tissue-type plasminogen activator (tPA) and its complex with the type-1 inhibitor (PAI-1) in breast cancer
-
de Witte JH, Sweep CG, Klijn JG, et al. Prognostic value of tissue-type plasminogen activator (tPA) and its complex with the type-1 inhibitor (PAI-1) in breast cancer. Br J Cancer 1999;80:286-94.
-
(1999)
Br J Cancer
, vol.80
, pp. 286-294
-
-
de Witte, J.H.1
Sweep, C.G.2
Klijn, J.G.3
-
14
-
-
0035873886
-
Functional evaluation of plasmin formation in primary breast cancer
-
Chappuis PO, Dieterich B, Sciretta V, et al. Functional evaluation of plasmin formation in primary breast cancer. J Clin Oncol 2001;19:2731-8.
-
(2001)
J Clin Oncol
, vol.19
, pp. 2731-2738
-
-
Chappuis, P.O.1
Dieterich, B.2
Sciretta, V.3
-
15
-
-
0033946825
-
Urokinase plasminogen activator system gene expression is increased in human breast carcinoma and its bone metastases-a comparison of normal breast tissue, non-invasive and invasive carcinoma and osseous metastases
-
Fisher JL, Field CL, Zhou H, Harris TL, Henderson MA, Choong PF. Urokinase plasminogen activator system gene expression is increased in human breast carcinoma and its bone metastases-a comparison of normal breast tissue, non-invasive and invasive carcinoma and osseous metastases. Breast Cancer Res Treat 2000;61:1-12.
-
(2000)
Breast Cancer Res Treat
, vol.61
, pp. 1-12
-
-
Fisher, J.L.1
Field, C.L.2
Zhou, H.3
Harris, T.L.4
Henderson, M.A.5
Choong, P.F.6
-
16
-
-
0036906177
-
uPAR: A versatile signalling orchestrator
-
Blasi F, Carmeliet P. uPAR: a versatile signalling orchestrator. Nat Rev Mol Cell Biol 2002;3:932-43.
-
(2002)
Nat Rev Mol Cell Biol
, vol.3
, pp. 932-943
-
-
Blasi, F.1
Carmeliet, P.2
-
17
-
-
0023223148
-
The receptor-binding sequence of urokinase. A biological function for the growth-factor module of proteases
-
Appella E, Robinson EA, Ullrich SJ, et al. The receptor-binding sequence of urokinase. A biological function for the growth-factor module of proteases. J Biol Chem 1987;262:4437-40.
-
(1987)
J Biol Chem
, vol.262
, pp. 4437-4440
-
-
Appella, E.1
Robinson, E.A.2
Ullrich, S.J.3
-
18
-
-
0028064814
-
Structure-function relationships in the receptor for urokinase-type plasminogen activator. Comparison to other members of the Ly-6 family and snake venom α-neurotoxins
-
Ploug M, Ellis V. Structure-function relationships in the receptor for urokinase-type plasminogen activator. Comparison to other members of the Ly-6 family and snake venom α-neurotoxins. FEBS Lett 1994;349:163-8.
-
(1994)
FEBS Lett
, vol.349
, pp. 163-168
-
-
Ploug, M.1
Ellis, V.2
-
19
-
-
43049130010
-
The urokinase plasminogen activator system in cancer: A putative therapeutic target?
-
Killeen S, Hennessey A, El Hassan Y, Waldron B. The urokinase plasminogen activator system in cancer: a putative therapeutic target? Drug News Perspect 2008;21:107-16.
-
(2008)
Drug News Perspect
, vol.21
, pp. 107-116
-
-
Killeen, S.1
Hennessey, A.2
El Hassan, Y.3
Waldron, B.4
-
20
-
-
0025867052
-
Effects of urokinase receptor occupancy on plasmin generation and proteolysis of basement membrane by human tumor cells
-
Cohen RL, Xi XP, Crowley CW, Lucas BK, Levinson AD, Shuman MA. Effects of urokinase receptor occupancy on plasmin generation and proteolysis of basement membrane by human tumor cells. Blood 1991;78:479-87.
-
(1991)
Blood
, vol.78
, pp. 479-487
-
-
Cohen, R.L.1
Xi, X.P.2
Crowley, C.W.3
Lucas, B.K.4
Levinson, A.D.5
Shuman, M.A.6
-
21
-
-
17844377315
-
Prognostic impact of urokinase-type plasminogen activator receptor (uPAR) in cytosols and pellet extracts derived from primary breast tumours
-
de Witte JH, Foekens JA, Brunner N, et al. Prognostic impact of urokinase-type plasminogen activator receptor (uPAR) in cytosols and pellet extracts derived from primary breast tumours. Br J Cancer 2001;85:85-92.
-
(2001)
Br J Cancer
, vol.85
, pp. 85-92
-
-
de Witte, J.H.1
Foekens, J.A.2
Brunner, N.3
-
24
-
-
0029834684
-
Overexpression of urokinase receptor in breast cancer cells results in increased tumor invasion, growth and metastasis
-
Xing RH, Rabbani SA. Overexpression of urokinase receptor in breast cancer cells results in increased tumor invasion, growth and metastasis. Int J Cancer 1996;67:423-9.
-
(1996)
Int J Cancer
, vol.67
, pp. 423-429
-
-
Xing, R.H.1
Rabbani, S.A.2
-
25
-
-
1542333510
-
Nipple aspirate fluid expression of urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor predicts breast cancer diagnosis and advanced disease
-
Qin W, Zhu W, Wagner-Mann C, Sauter ER. Nipple aspirate fluid expression of urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor predicts breast cancer diagnosis and advanced disease. Ann Surg Oncol 2003;10:948-53.
-
(2003)
Ann Surg Oncol
, vol.10
, pp. 948-953
-
-
Qin, W.1
Zhu, W.2
Wagner-Mann, C.3
Sauter, E.R.4
-
26
-
-
0028889256
-
Prognostic significance of the receptor for urokinase plasminogen activator in breast cancer
-
Grondahl-Hansen J, Peters HA, van Putten WL, et al. Prognostic significance of the receptor for urokinase plasminogen activator in breast cancer. Clin Cancer Res 1995;1:1079-87.
-
(1995)
Clin Cancer Res
, vol.1
, pp. 1079-1087
-
-
Grondahl-Hansen, J.1
Peters, H.A.2
van Putten, W.L.3
-
27
-
-
11144358203
-
Antisense oligodeoxynucleotides for urokinase-plasminogen activator receptor have anti-invasive and anti-proliferative effects in vitro and inhibit spontaneous metastases of human melanoma in mice
-
D'Alessio S, Margheri F, Pucci M, et al. Antisense oligodeoxynucleotides for urokinase-plasminogen activator receptor have anti-invasive and anti-proliferative effects in vitro and inhibit spontaneous metastases of human melanoma in mice. Int J Cancer 2004;110:125-33.
-
(2004)
Int J Cancer
, vol.110
, pp. 125-133
-
-
D'Alessio, S.1
Margheri, F.2
Pucci, M.3
-
28
-
-
3042551389
-
Adenovirus-mediated expression of antisense urokinase plasminogen activator receptor and antisense cathepsin B inhibits tumor growth, invasion, and angiogenesis in gliomas
-
Gondi CS, Lakka SS, Yanamandra N, et al. Adenovirus-mediated expression of antisense urokinase plasminogen activator receptor and antisense cathepsin B inhibits tumor growth, invasion, and angiogenesis in gliomas. Cancer Res 2004;64:4069-77.
-
(2004)
Cancer Res
, vol.64
, pp. 4069-4077
-
-
Gondi, C.S.1
Lakka, S.S.2
Yanamandra, N.3
-
29
-
-
0037089470
-
Urokinase receptor antibody can reduce tumor volume and detect the presence of occult tumor metastases in vivo
-
Rabbani SA, Gladu J. Urokinase receptor antibody can reduce tumor volume and detect the presence of occult tumor metastases in vivo. Cancer Res 2002;62:2390-7.
-
(2002)
Cancer Res
, vol.62
, pp. 2390-2397
-
-
Rabbani, S.A.1
Gladu, J.2
-
30
-
-
0036252492
-
High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of immunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter
-
Demaison C, Parsley K, Brouns G, et al. High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of immunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter. Hum Gene Ther 2002;13:803-13.
-
(2002)
Hum Gene Ther
, vol.13
, pp. 803-813
-
-
Demaison, C.1
Parsley, K.2
Brouns, G.3
-
31
-
-
33745246331
-
Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model
-
Merchan JR, Tang J, Hu G, et al. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model. J Natl Cancer Inst 2006;98:756-64.
-
(2006)
J Natl Cancer Inst
, vol.98
, pp. 756-764
-
-
Merchan, J.R.1
Tang, J.2
Hu, G.3
-
32
-
-
13844254649
-
Rescue and propagation of fully retargeted oncolytic measles viruses
-
Nakamura T, Peng KW, Harvey M, et al. Rescue and propagation of fully retargeted oncolytic measles viruses. Nat Biotechnol 2005;23:209-14.
-
(2005)
Nat Biotechnol
, vol.23
, pp. 209-214
-
-
Nakamura, T.1
Peng, K.W.2
Harvey, M.3
-
33
-
-
0037420209
-
In vitro and in vivo induction of antiangiogenic activity by plasminogen activators and captopril
-
Merchan JR, Chan B, Kale S, Schnipper LE, Sukhatme VP. In vitro and in vivo induction of antiangiogenic activity by plasminogen activators and captopril. J Natl Cancer Inst 2003;95:388-99.
-
(2003)
J Natl Cancer Inst
, vol.95
, pp. 388-399
-
-
Merchan, J.R.1
Chan, B.2
Kale, S.3
Schnipper, L.E.4
Sukhatme, V.P.5
-
34
-
-
11144261691
-
Increased endothelial uptake of paclitaxel as a potential mechanism for its antiangiogenic effects: Potentiation by Cox-2 inhibition
-
Merchan JR, Jayaram DR, Supko JG, He X, Bubley GJ, Sukhatme VP. Increased endothelial uptake of paclitaxel as a potential mechanism for its antiangiogenic effects: potentiation by Cox-2 inhibition. Int J Cancer 2005;113:490-8.
-
(2005)
Int J Cancer
, vol.113
, pp. 490-498
-
-
Merchan, J.R.1
Jayaram, D.R.2
Supko, J.G.3
He, X.4
Bubley, G.J.5
Sukhatme, V.P.6
-
35
-
-
33846213523
-
Retargeted oncolytic measles strains entering via the EGFRvIII receptor maintain significant antitumor activity against gliomas with increased tumor specificity
-
Allen C, Vongpunsawad S, Nakamura T, et al. Retargeted oncolytic measles strains entering via the EGFRvIII receptor maintain significant antitumor activity against gliomas with increased tumor specificity. Cancer Res 2006;66:11840-50.
-
(2006)
Cancer Res
, vol.66
, pp. 11840-11850
-
-
Allen, C.1
Vongpunsawad, S.2
Nakamura, T.3
-
36
-
-
0037843576
-
Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme
-
Phuong LK, Allen C, Peng KW, et al. Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme. Cancer Res 2003;63:2462-9.
-
(2003)
Cancer Res
, vol.63
, pp. 2462-2469
-
-
Phuong, L.K.1
Allen, C.2
Peng, K.W.3
-
37
-
-
0031835231
-
Binding of human urokinase-type plasminogen activator to its receptor: Residues involved in species specificity and binding
-
Quax PH, Grimbergen JM, Lansink M, et al. Binding of human urokinase-type plasminogen activator to its receptor: residues involved in species specificity and binding. Arterioscler Thromb Vasc Biol 1998;18:693-701.
-
(1998)
Arterioscler Thromb Vasc Biol
, vol.18
, pp. 693-701
-
-
Quax, P.H.1
Grimbergen, J.M.2
Lansink, M.3
-
39
-
-
0030788411
-
The urokinase-type plasminogen activator system in cancer metastasis: A review
-
Andreasen PA, Kjoller L, Christensen L, Duffy MJ. The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 1997;72:1-22.
-
(1997)
Int J Cancer
, vol.72
, pp. 1-22
-
-
Andreasen, P.A.1
Kjoller, L.2
Christensen, L.3
Duffy, M.J.4
-
40
-
-
0028968307
-
Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells
-
Mandriota SJ, Seghezzi G, Vassalli JD, et al. Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells. J Biol Chem 1995;270:9709-16.
-
(1995)
J Biol Chem
, vol.270
, pp. 9709-9716
-
-
Mandriota, S.J.1
Seghezzi, G.2
Vassalli, J.D.3
-
41
-
-
3042784666
-
Vascular endothelial growth factor receptor-2-in-duced initial endothelial cell migration depends on the presence of the urokinase receptor
-
Prager GW, Breuss JM, Steurer S, et al. Vascular endothelial growth factor receptor-2-in-duced initial endothelial cell migration depends on the presence of the urokinase receptor. Circ Res 2004;94:1562-70.
-
(2004)
Circ Res
, vol.94
, pp. 1562-1570
-
-
Prager, G.W.1
Breuss, J.M.2
Steurer, S.3
-
42
-
-
3042743709
-
The urokinase receptor as a potential target in cancer therapy
-
Romer J, Nielsen BS, Ploug M. The urokinase receptor as a potential target in cancer therapy. Curr Pharm Des 2004;10:2359-76.
-
(2004)
Curr Pharm Des
, vol.10
, pp. 2359-2376
-
-
Romer, J.1
Nielsen, B.S.2
Ploug, M.3
-
43
-
-
34548414532
-
Targeting uPA/uPARin prostate cancer
-
Li Y, Cozzi PJ. Targeting uPA/uPARin prostate cancer. Cancer Treat Rev 2007;33:521-7.
-
(2007)
Cancer Treat Rev
, vol.33
, pp. 521-527
-
-
Li, Y.1
Cozzi, P.J.2
-
44
-
-
33947226800
-
Epidermal growth factor receptor (EGFR)-retargeted measles virus strains effectively target EGFR-or EGFRvIII expressing gliomas
-
Paraskevakou G, Allen C, Nakamura T, et al. Epidermal growth factor receptor (EGFR)-retargeted measles virus strains effectively target EGFR-or EGFRvIII expressing gliomas. Mol Ther 2007;15:677-86.
-
(2007)
Mol Ther
, vol.15
, pp. 677-686
-
-
Paraskevakou, G.1
Allen, C.2
Nakamura, T.3
-
45
-
-
35549009347
-
An immunocompetent murine model for oncolysis with an armed and targeted measles virus
-
Ungerechts G, Springfeld C, Frenzke ME, et al. An immunocompetent murine model for oncolysis with an armed and targeted measles virus. Mol Ther 2007;15:1991-7.
-
(2007)
Mol Ther
, vol.15
, pp. 1991-1997
-
-
Ungerechts, G.1
Springfeld, C.2
Frenzke, M.E.3
-
46
-
-
0024994008
-
Vascular and interstitial barriers to delivery of therapeutic agents in tumors
-
Jain RK. Vascular and interstitial barriers to delivery of therapeutic agents in tumors. Cancer Metastasis Rev 1990;9:253-66.
-
(1990)
Cancer Metastasis Rev
, vol.9
, pp. 253-266
-
-
Jain, R.K.1
-
47
-
-
33645752057
-
Tumor vascular targeting therapy with viral vectors
-
Liu Y, Deisseroth A. Tumor vascular targeting therapy with viral vectors. Blood 2006;107:3027-33.
-
(2006)
Blood
, vol.107
, pp. 3027-3033
-
-
Liu, Y.1
Deisseroth, A.2
-
48
-
-
0029860972
-
Tumor cell-conditioned medium stimulates expression of the urokinase receptor in vascular endothelial cells
-
Seghezzi G, Marelli R, Mandriota S J, Nolli ML, Mazzieri R, Mignatti P. Tumor cell-conditioned medium stimulates expression of the urokinase receptor in vascular endothelial cells. J Cell Physiol 1996;169:300-8.
-
(1996)
J Cell Physiol
, vol.169
, pp. 300-308
-
-
Seghezzi, G.1
Marelli, R.2
Mandriota, S.J.3
Nolli, M.L.4
Mazzieri, R.5
Mignatti, P.6
-
49
-
-
0028347646
-
The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue
-
Bianchi E, Cohen RL, Thor AT, et al. The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue. Cancer Res 1994;54:861-6.
-
(1994)
Cancer Res
, vol.54
, pp. 861-866
-
-
Bianchi, E.1
Cohen, R.L.2
Thor, A.T.3
|